WHO Western Pacific Regional Director encouraged by China’s progress on tobacco control, urges strong next steps
BEIJING, 26 February 2014 – The World Health Organisation is greatly encouraged by the current momentum in China for stronger tobacco control measures, but is urging the country to take even stronger steps to reverse the toll of tobacco-related illness now and in the future.
WHO applauds China for significant public health achievements including hepatitis B reduction and ongoing health sector reform
BEIJING, 25 February 2014 - The World Health Organisation has recognized China’s significant public health achievements in reducing hepatitis B prevalence and pressing ahead with large scale health sector reform.
WHO Western Pacific Regional Director Dr Shin Young-soo, on an official visit to Beijing this week, presented an award to Minister Li Bin and the National Health and Family Planning Commission (NHFPC) to mark China’s historic reduction of hepatitis B among young children.
BEIJING, 22 January 2014 – The World Health Organization (WHO) has been officially notified by the China health authorities of more laboratory-confirmed cases of human infection with avian influenza A (H7N9) virus, since 1 January 2014. There is no evidence of sustained human-to-human transmission.
Given the population movement prior to Chinese New Year and potentially unpredictable behaviour of influenza viruses, continued vigilance and close monitoring are needed. WHO’s advice to the public is to continue to practice good hygiene and handle food properly. WHO does not recommend any travel or trade restriction.
BEIJING, 22 January 2014 – On January 17, 2014, the China Food and Drug Administration and the National Health and Family Planning Commission announced resumption of the use of hepatitis B vaccine produced by Biokangtai Biologic Products. The use of this vaccine had been temporarily suspended on December 20, 2013, pending an investigation into the quality and production of the vaccine. The investigation included 17 infant deaths and 1 case of allergic shock. All these cases received the Hepatitis B vaccine from the same manufacturer.
- WHO Western Pacific Regional Director encouraged by China’s progress on tobacco control, urges strong next steps
- WHO applauds China for significant public health achievements including hepatitis B reduction and ongoing health sector reform
- Avian influenza A (H7N9) in China
- China resumed the use of BioKangtai's hepatitis B vaccines
Highlights from the country
9 October 2013
Newly accessible Japanese encephalitis vaccine will make saving children easier in developing countries
A newly accessible vaccine against Japanese Encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other JE vaccines.
12 November 2013
Achieving global targets: Healthy lifestyles to prevent and control non-communicable diseases
Non-communicable diseases (NCDs) —including cardiovascular diseases, diabetes, cancers and chronic respiratory diseases—are the number one public health threat, killing more than 36 million people each year globally. In China, NCDs account for over 80 per cent of its annual deaths and contribute to almost 70 per cent of the total disease burden.
30 January 2013
WHO China launches new bilingual website
BEIJING, 30 January 2013 - The World Health Organization (WHO) Country Office in China today launched a new bilingual (English and Chinese) website to share its work more broadly and strengthen its capacity to help improve the health and well-being of the people of China.